4.6 Article

The RING finger- and PDZ domain-containing protein PDZRN3 controls localization of the Mg2+ regulator claudin-16 in renal tube epithelial cells

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 292, 期 31, 页码 13034-13044

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M117.779405

关键词

E3 ubiquitin ligase; kidney; magnesium; protein phosphorylation; tight junction

资金

  1. JSPS KAKENHI [15H04657]
  2. Salt Science Research Foundation [1627]
  3. Mishima Kaiun Memorial Foundation
  4. Grants-in-Aid for Scientific Research [17H05030, 15H04657] Funding Source: KAKEN

向作者/读者索取更多资源

Ion exchange in the renal tubules is fundamental to the maintenance of physiological ion levels. Claudin-16 (CLDN16) regulates the paracellular reabsorption of Mg2+ in the thick ascending limb of Henle's loop in the kidney, with dephosphorylation of CLDN16 increasing its intracellular distribution and decreasing paracellular Mg2+ permeability. CLDN16 is located in the tight junctions, but the mechanism regulating its localization is unclear. Using yeast two-hybrid systems, we found that CLDN16 binds to PDZRN3, a protein containing both RING-finger and PDZ domains. We also observed that the carboxyl terminus of the cytoplasmic CLDN16 region was required for PDZRN3 binding. PZDRN3 was mainly distributed in the cytosol of rat kidney cells and upon cell treatment with the protein kinase A inhibitor H-89, colocalized with CLDN16. H-89 also increased mono-ubiquitination and the association of CLDN16 with PDZRN3. Mono-ubiquitination levels of a K275A mutant were lower, and its association with PDZRN3 was reduced compared with wild-type (WT) CLDN16 and a K261A mutant, indicating that Lys-275 is the major ubiquitination site. An S217A mutant, a dephosphorylated form of CLDN16, localized to the cytosol along with PDZRN3 and the endosomal marker Rab7. PDZRN3 siRNA increased cell-surface localization of WT CLDN16 in H-89-treated cells or containing the S217A mutant and also suppressed CLDN16 endocytosis. Of note, H-89 decreased paracellular Mg2+ flux in WT CLDN16 cells, and PDZRN3 siRNA increased Mg2+ flux in the H-89-treated WT CLDN16 and S217A mutant cells. These results suggest that PDZRN3 mediates endocytosis of dephosphorylated CLDN16 and represents an important component of the CLDN16-trafficking machinery in the kidney.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

L-type amino acid transporter 1 as a target for inflammatory disease and cancer immunotherapy

Keitaro Hayashi, Naohiko Anzai

Summary: Ingestion of amino acids plays a crucial role in cellular activities, especially in immune cell metabolic reprogramming. Transport of amino acids by transporters is essential for the progression of metabolic rewiring. Targeting amino acid transporters may offer potential for improving immune disorders and cancer immune therapies.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Review Oncology

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways

Xue Zhao, Shinichi Sakamoto, Maihulan Maimaiti, Naohiko Anzai, Tomohiko Ichikawa

Summary: LAT1-4F2hc complex is an important amino acid transporter involved in urological cancers. Inhibiting LAT1-4F2hc complex shows promise as a targeted therapy for these cancers.

CANCERS (2022)

Correction Chemistry, Medicinal

Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer (vol 65, pg 4878, 2022)

Yudai Kudo, Satoshi Endo, Mei Fujita, Atsumi Ota, Yuji O. Kamatari, Yoshimasa Tanaka, Takeshi Ishikawa, Hayato Ikeda, Takuya Okada, Naoki Toyooka, Naohiro Fujimoto, Toshiyuki Matsunaga, Akira Ikari

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery and Structure-Based Optimization of Novel Atg4BInhibitors for the Treatment of Castration-Resistant Prostate Cancer

Yudai Kudo, Satoshi Endo, Mei Fujita, Atsumi Ota, Yuji O. Kamatari, Yoshimasa Tanaka, Takeshi Ishikawa, Hayato Ikeda, Takuya Okada, Naoki Toyooka, Naohiro Fujimoto, Toshiyuki Matsunaga, Akira Ikari

Summary: This study discovered inhibitors of Atg4B, a key enzyme in autophagosome formation, and evaluated their potential as therapeutics for prostate cancer. Compound 17 showed the most potent Atg4B inhibitory activity and enhanced the anticancer activity of anti-CRPC drugs. Through structural optimization, compound 21f was developed as a competitive inhibitor with strong inhibitory activity against Atg4B.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Pharmacology & Pharmacy

Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparations

Motoshi Ouchi, Asuka Morita, Keitaro Satoh, Shunsuke Kobayashi, Misao Terada, Hiroe Kon, Keitaro Hayashi, Tatsuya Suzuki, Kenzo Oba, Hitoshi Sugihara, Masahiro Yasutake, Naohiko Anzai, Tomoe Fujita

Summary: This study aimed to assess the effects of short-term stimulation with 1,5-AG on insulin secretion. The results indicated that 1,5-AG had no significant effect on insulin secretion, while stimulation with glimepiride significantly increased insulin secretion.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2022)

Article Biochemistry & Molecular Biology

Hypouricemia and Urate Transporters

Naoyuki Otani, Motoshi Ouchi, Kazuharu Misawa, Ichiro Hisatome, Naohiko Anzai

Summary: Hypouricemia, a rare disorder, is divided into overexcretion and underproduction types. Renal hypouricemia, the latter type, is the most common in Japan and can increase the risk of exercise-induced acute kidney injury and urolithiasis. It is crucial to conduct research on renal hypouricemia to gain insight into its pathophysiology and develop new treatments for gout and hyperuricemia.

BIOMEDICINES (2022)

Article Immunology

LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse

Takayoshi Owada, Kazuhiro Kurasawa, Hitoshi Endou, Tomoe Fujita, Naohiko Anzai, Keitaro Hayashi

Summary: The study shows that LAT1 plays a crucial role in T helper-mediated autoimmune arthritis and suggests a potential therapeutic approach targeting amino acid transporters for treating hypersensitive immune diseases.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression

Hiroaki Eguchi, Riho Kimura, Haruka Matsunaga, Toshiyuki Matsunaga, Yuta Yoshino, Satoshi Endo, Akira Ikari

Summary: This study found that fisetin can enhance the toxicity of anticancer drugs in A549 lung adenocarcinoma spheroids by reducing CLDN2 expression, potentially through inhibiting the PI3K/Akt signaling pathway and affecting hypoxia levels in the tumor microenvironment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

P2X7 Receptors in Astrocytes: A Switch for Ischemic Tolerance

Yuri Hirayama, Naohiko Anzai, Hiroyuki Kinouchi, Schuichi Koizumi

Summary: Preconditioning can protect neurons against lethal ischemic injury, known as ischemic tolerance. P2X7 receptors in astrocytes play a crucial role in preconditioning, acting as a switch to protect the brain against ischemia by transforming into an ischemia-resistant phenotype.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Elevation of Anticancer Drug Toxicity by Caffeine in Spheroid Model of Human Lung Adenocarcinoma A549 Cells Mediated by Reduction in Claudin-2 and Nrf2 Expression

Hiroaki Eguchi, Riho Kimura, Saki Onuma, Ayaka Ito, Yaqing Yu, Yuta Yoshino, Toshiyuki Matsunaga, Satoshi Endo, Akira Ikari

Summary: Claudin-2 is abnormally expressed in lung adenocarcinoma, and caffeine and theobromine can decrease its protein level, while enhancing the toxicity of doxorubicin in A549 cells. This effect may be achieved by accelerating lysosomal degradation of CLDN2 and reducing Nrf2 expression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Antiandrogenic Effects of a Polyphenol in Carex kobomugi through Inhibition of Androgen Synthetic Pathway and Downregulation of Androgen Receptor in Prostate Cancer Cell Lines

Yudai Kudo, Satoshi Endo, Masatoshi Tanio, Tomofumi Saka, Rin Himura, Naohito Abe, Mitsumi Takeda, Eiji Yamaguchi, Yuta Yoshino, Yuki Arai, Hirohito Kashiwagi, Masayoshi Oyama, Akichika Itoh, Masaki Shiota, Naohiro Fujimoto, Akira Ikari

Summary: This study reveals the important roles of adrenal-derived 11-oxygenated androgens and DHRS11 in the progression of prostate cancer. It also identifies a novel DHRS11 inhibitor, KC-A, which suppresses androgen signaling and enhances the anticancer activity of a CRPC drug. These findings suggest that KC-A may be a potential candidate for the prevention and treatment of CRPC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Availability of aldo-keto reductase 1C3 and ATP-binding cassette B1 as therapeutic targets for alleviating paclitaxel resistance in breast cancer MCF7 cells

Toshiyuki Matsunaga, Misato Horinouchi, Haruhi Saito, Aki Hisamatsu, Kazuhiro Iguchi, Yuta Yoshino, Satoshi Endo, Akira Ikari

Summary: Paclitaxel (PTX) is commonly used for breast cancer chemotherapy, but continuous treatment causes hyposensitivity. This study found that acquiring chemoresistance leads to up-regulation of aldo-keto reductase (AKR) 1C3. Inhibiting AKR1C3 and reducing its expression increased MCF7 cell sensitivity to PTX, while overexpression of AKR1C3 decreased sensitivity. The resistant cells were less sensitive to cytotoxic aldehydes derived from ROS-mediated lipid peroxidation and showed reduced levels of these aldehydes during PTX treatment. AKR1C3 inhibition mitigated this reduction, suggesting its role in the development of PTX resistance. The resistance also promoted abnormal expression of ABC transporter ABCB1, and combined treatment with AKR1C3 and ABCB1 inhibitors overcame PTX resistance and cross-resistance to docetaxel.

JOURNAL OF BIOCHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Characterization of a novel porcine carbonyl reductase activated by glutathione: Relationship to carbonyl reductase 1, 3α/β-hydroxysteroid dehydrogenase and prostaglandin 9-ketoreductase

Satoshi Endo, Yoshifumi Morikawa, Toshiyuki Matsunaga, Akira Hara, Masaki Takasu

Summary: A porcine gene, LOC100622246, encodes carbonyl reductase [NADPH] 1 (pCBR-N1), whose function remains unknown. Previously, three porcine carbonyl reductases, carbonyl reductase 1 (pCBR1), 3 alpha/ss-hydroxysteroid dehydrogenase (p3 alpha/ss-HSD) and prostaglandine-9-keto reductase (pPG-9-KR), were purified from different pig tissues. The relationship between pCBR-N1 and these three enzymes is still unknown. This study compared the properties of pCBR-N1 and pCBR1 and found that pCBR-N1 is identical to p3 alpha/ss-HSD and pPG-9-KR. pCBR-N1 is a glutathione-activated carbonyl reductase that functions in the metabolism of endogenous and xenobiotic carbonyl compounds.

CHEMICO-BIOLOGICAL INTERACTIONS (2023)

Article Medicine, Research & Experimental

The Effects of Trypsin Inhibitor on Insulin Secretion Using Rat Pancreas in an Organ Bath

Asuka Morita, Motoshi Ouchi, Keitaro Satoh, Shunsuke Kobayashi, Misao Terada, Hidefumi Wakashin, Hiroe Kon, Keitaro Hayashi, Naohiko Anzai, Akira Shimizu, Hitoshi Sugihara, Kenzo Oba, Tomoe Fujita

Summary: The study found that even low concentrations of trypsin inhibitor can maintain insulin secretion in organ bath experiments by inhibiting trypsin activity. This research result provides an important experimental basis for further studies on pancreas-related diseases.

IN VIVO (2021)

Meeting Abstract Biochemistry & Molecular Biology

Effects of trypsin inhibition on endocrine function in isolated rat pancreas

Asuka Morita, Motoshi Ouchi, Keitaro Satoh, Shunsuke Kobayashi, Naohiko Anzai, Akira Shimizu, Hitoshi Sugihara, Kenzo Oba, Tomoe Fujita

FASEB JOURNAL (2021)

暂无数据